Poly Medicure Standalone March 2021 Net Sales at Rs 202.51 crore, up 27.22% Y-o-Y
NULL24-05-2021
POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an earnings call will be held on Tuesday, 25th May, 2021 at 3.00 p.m. (IST) for discussing the Audited Financial Results of the Company for the Financial Year ended 31st March, 2021. Link for joining, Dial in and other details of the call are enclosed herewith. This is for your information and record.24-05-2021
Poly Medicure Ltd - 531768 - Board recommends Dividend
Poly Medicure Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2021, inter alia, has approved the following:- Recommendation of Dividend of Rs. 2.5 (Two and half Rupees) per Equity Shares (50%) of Rs. 5 each for the Financial Year 2020-21, subject to the approval of shareholders.24-05-2021
Poly Medicure Ltd - 531768 - Outcome Of The Board Meeting Of The Company Dated 24Th May, 2021.
Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 24th May, 2021, at 232-B, 3RD Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110020, approved the following businesses: a) Audited Financial Results (Consolidate & Standalone) for the year ended on 31st March 2021. b) Recommendation of Dividend of Rs. 2.5 (Two and half Rupees) per Equity Shares (50%) of Rs. 5 each for the Financial Year 2020-21, subject to the approval of shareholders.24-05-2021
POLY MEDICURE LTD. - 531768 - Board to consider FY21 results & Final Dividend on May 24, 2021
Poly Medicure Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 24, 2021, inter alia to consider the following:1. To consider and approve the Audited Financial Results (Consolidated & Standalone) of the Company for the financial year ended on March 31, 2021.2. To consider recommendation of Final Dividend, if any. on the Equity Shares for the financial year ended on March 31, 2021.In continuation of intimation regarding closure of trading window vide letter dated March 31, 2021 , the Trading Window for dealing in securities of the Company shall remain closed till *May 26, 2021.14-05-2021
Poly Medicure Ltd - 531768 - Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On 24Th May, 2021
POLY MEDICURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2021 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, notice is hereby given that a meeting of the Board of Directors of the Company will be held on Monday, the 24th May, 2021, inter alia to consider the following: a) To consider and approve the Audited Financial Results (Consolidated & Standalone) of the Company for the financial year ended on 31st March, 2021. b) To consider recommendation of Final Dividend, if any, on the Equity Shares for the financial year ended on 31st March, 2021. c) To transact any other matter which the Board may deem fit. In continuation of our intimation regarding closure of trading window vide letter dated 31st March, 2021, the Trading Window for dealing in securities of the Company shall remain closed till 26th May, 2021. This is for your information and record.14-05-2021
Poly Medicure Ltd - 531768 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayPOLY MEDICURE LTD. 2CINL40300DL1995PLC066923 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 60.00 4Highest Credit Rating during the previous FY A+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Avinash Chandra Designation: Company Secretary EmailId: cs@polymedicure.com Name of the Chief Financial Officer: J K Oswal Designation: CFO EmailId: jkoswal@polymedicure.com Date: 30/04/2021 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.30-04-2021
POLY MEDICURE LTD. - 531768 - Compliances- Compliance Certificate For The Period Ended 31St March, 2021
Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained by the Company's Registrar and Share Transfer Agent, viz., Mas Services Limited, which is a SEBI approved category-I, Registrar & Transfer Agent, registered with Securities and Exchange Board of India (SEBI Registration Number : INR000000049).29-04-2021
Poly Medicure Ltd - 531768 - Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended On 31St March, 2021
Pursuant to the regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the certificate issued by practicing Company Secretary for the half year ended on 31st March, 2021. This is for your information and record.22-04-2021